Embed Size (px)
Citation preview
Global Depressive Disorder Market- Industry
Analysis & Outlook (2016-2020)
-----------------------------------------
View Report Details
Executive Summary
Depression is a serious mood disorder, affecting the ability to think, feel, and handle situations like sleeping, eating, or
working. It is a mood disorder that causes a persistent feeling of sadness and loss of interest.
It builds up a very negative perspective in the way of thinking in every single thing and damages a person’s ability to
see brighter versions of any situation in life. It is of various types like major depressive disorder (MDD), perinatal
depression, psychotic depression, seasonal depression and bipolar depression.
To be diagnosed with depression, the symptoms must be present for at least two weeks. It may require long-term
treatment for years. There is no single cause of depression; it is likely an outcome from combinations of genetic,
biochemical, environmental and physiological factors.
There are several ways of treating depression depending upon each individual’s characteristics & symptoms. Most
people feel better with medication, psychological counseling or both.
The global depressive disorder market is expected to grow and overcome falling revenues due to patent expiry with
better innovative drugs and therapies. The US has highest depression disorder prevalence along with highest
prevalence of bipolar depression & schizophrenia.
With growing awareness and better access to medical facilities, the depressive disorder market is expected to grow
worldwide, especially in Asia-Pacific region.
The key factors driving the growth of the depressive disorder market includes increased smoking prevalence, rising
healthcare expenditure, growing female population, increasing spending on medicines and rising number of prescription
drugs.
However, there are certain factors hindering the growth of the market like patent expiry, severe side effects of drugs,
and tough regulations. Major trends of the market include novel drug approvals, major drugs in pipeline, and growing
public awareness.
The report offers an in-depth analysis of the “Global Depressive Disorder Market” segmented into global and regional
markets. Competition is concentrated in the hands of few major pharmaceutical companies out of which Pfizer Inc.,
AstraZeneca, Eli Lilly and company, and Lundbeck have been covered in the report.
View Report Details
Global depressive disorder market has registered a fluctuating growth in the last few years owing to introduction of new drugs largely offset by patent expiry of leading drugs….
The global depressive disorder market revenue reached US$..
billion in 2015, decreasing from US$.. billion in the previous fiscal
year. The market recorded negative growth at a CAGR of ..% for
the period spanning 2010-2015.
The revenue of the global anti-depressant drug market reached
US$.. billion in 2015, decreasing from US$.. billion in the previous
fiscal year. The market experienced a negative growth at a
CAGR of ..% for the period spanning 2010-2015.
The global anti-psychotic drug market revenue is expected to be
recorded at US$.. billion by 2020, increasing from US$.. billion in
the previous fiscal year. The market is expected to grow at a
CAGR of ..% for the period spanning 2016-2020.
Global Anti-Depressant Drug Market by Value (2010-2015)
Global Depressive Disorder Market by Value (2010-2015)
Global Anti-Psychotic Drug Market Forecast by Value (2016-2020)
2010 2011 2012 2013 2014 2015
US
$ B
illion
Revenue Annual Growth
2010 2011 2012 2013 2014 2015
US
$ B
illion
Revenue Annual Growth
2016 2017 2018 2019 2020
US
$ B
illion
Revenue Annual Growth
The global depressive disorder market is driven by increasing awareness, rapid acting depressant drugs in development and novel drug approvals …
The US depression disorder market revenue is expected to reach
US$.. billion by 2020, undergoing a decline until 2018 and
recovering slowly thereafter, recording negative growth at a CAGR
of ..% for the period spanning 2015-2020.
The prevalence of depressive disorder in the US is expected to
reach .. million by 2020, increasing from .. million in 2016.
The European depression disorder market revenue is expected to
reach US$.. billion by 2020.
The European depression disorder market will record growth at a
CAGR of ..% for the period spanning 2015-2020.
The US Depressive Disorder Patient Prevalence Forecast (2016-2020)
The US Depressive Disorder Market Forecast by Value (2015-2020)
European Depression Disorder Market Forecast by Value (2015-2020)
2015 2016 2017 2018 2019 2020
US
$ B
illion
2016 2017 2018 2019 2020
Million
3.00
3.50
4.00
4.50
5.00
5.50
2015 2016 2017 2018 2019 2020
US
$ B
illion
The global depressive disorder market growth is likely to be challenged by patent expiry of many drugs , stringent regulations, and harsh side effects of drugs..
China’s anti-depressant drug market revenue was recorded at US$..
million in 2015, increasing from US$.. million in the previous fiscal
year. It recorded growth at a CAGR of ..% for the period spanning
2010-2015.
China’s anti-psychotic drug market revenue was recorded at US$..
million in 2015, increasing from US$.. million in the previous fiscal
year. The market recorded an annual growth of ..% in 2015.
The US schizophrenia patient prevalence is expected to reach ..
thousand by 2020, increasing from .. thousand in 2016. The patient’s
prevalence is expected to grow at a CAGR of ..% for the period
spanning 2016-2020.
China Anti-Psychotic Drug Market by Value (2010-2015)
China Anti-Depressant Drug Market by Value (2010-2015)
The US Schizophrenia Patient Prevalence Forecast (2016-2020)
2010 2011 2012 2013 2014 2015
US
$ M
illion
Revenue Annual Growth
2010 2011 2012 2013 2014 2015
US
$ M
illion
Revenue Annual Growth 2016 2017 2018 2019 2020
Thousands
Koncept Analytics
CS-36, Second Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
T. +91-120-4130959
C: +91-9811715635
Contact Us:
www.konceptanalytics.com
Vikas Gupta
BD Manager
These are abridged and sanitized sample pages from the comprehensive report on the “ Global Depression Disorder
Market-2016 Edition ”. To know more about this report or for any customized research requirement, please contact the
following:
View Report Details
